280 related articles for article (PubMed ID: 15287031)
21. Theophylline induced differentiation provides direct evidence for the deregulation of c-myc in Burkitt's lymphoma and suggests participation of immunoglobulin enhancer sequences.
Sandlund JT; Neckers LM; Schneller HE; Woodruff LS; Magrath IT
Cancer Res; 1993 Jan; 53(1):127-32. PubMed ID: 8416737
[TBL] [Abstract][Full Text] [Related]
22. Epstein-Barr virus nuclear antigen 2 is a transcriptional suppressor of the immunoglobulin mu gene: implications for the expression of the translocated c-myc gene in Burkitt's lymphoma cells.
Jochner N; Eick D; Zimber-Strobl U; Pawlita M; Bornkamm GW; Kempkes B
EMBO J; 1996 Jan; 15(2):375-82. PubMed ID: 8617212
[TBL] [Abstract][Full Text] [Related]
23. Burkitt t(8;14)(q24;q32) and cryptic deletion in a CLL patient: report of a case and review of literature.
Reddy K; Satyadev R; Bouman D; Hibbard MK; Lu G; Paolo R
Cancer Genet Cytogenet; 2006 Apr; 166(1):12-21. PubMed ID: 16616107
[TBL] [Abstract][Full Text] [Related]
24. Variable breakpoints in Burkitt lymphoma cells with chromosomal t(8;14) translocation separate c-myc and the IgH locus up to several hundred kb.
Joos S; Falk MH; Lichter P; Haluska FG; Henglein B; Lenoir GM; Bornkamm GW
Hum Mol Genet; 1992 Nov; 1(8):625-32. PubMed ID: 1301171
[TBL] [Abstract][Full Text] [Related]
25. Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc.
Joos S; Haluska FG; Falk MH; Henglein B; Hameister H; Croce CM; Bornkamm GW
Cancer Res; 1992 Dec; 52(23):6547-52. PubMed ID: 1330296
[TBL] [Abstract][Full Text] [Related]
26. Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells.
Madisen L; Groudine M
Genes Dev; 1994 Sep; 8(18):2212-26. PubMed ID: 7958890
[TBL] [Abstract][Full Text] [Related]
27. t(8;14;18): a 3-way chromosome translocation in two patients with Burkitt's lymphoma/leukemia.
Liu D; Shimonov J; Primanneni S; Lai Y; Ahmed T; Seiter K
Mol Cancer; 2007 Jun; 6():35. PubMed ID: 17547754
[TBL] [Abstract][Full Text] [Related]
28. Preferential clustering of chromosomal breakpoints in Burkitt's lymphomas and L3 type acute lymphoblastic leukemias with a t(8;14) translocation.
Saglio G; Grazia Borrello M; Guerrasio A; Sozzi G; Serra A; di Celle PF; Foa R; Ferrarini M; Roncella S; Borgna Pignatti C
Genes Chromosomes Cancer; 1993 Sep; 8(1):1-7. PubMed ID: 7691153
[TBL] [Abstract][Full Text] [Related]
29. Activation of the c-myc p1 promoter in Burkitt's lymphoma by the hs3 immunoglobulin heavy-chain gene enhancer.
Hu HM; Kanda K; Zhang L; Boxer LM
Leukemia; 2007 Apr; 21(4):747-53. PubMed ID: 17287852
[TBL] [Abstract][Full Text] [Related]
30. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
Eick D; Polack A; Kofler E; Bornkamm GW
Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
[TBL] [Abstract][Full Text] [Related]
31. Allele-specific activation of the c-myc gene in an atypical Burkitt's lymphoma carrying the t(2;8) chromosomal translocation 250 kb downstream from c-myc.
Tachibana K; Takayama N; Matsuo K; Kato S; Yamamoto K; Ohyama K; Umezawa A; Takano T
Gene; 1993 Feb; 124(2):231-7. PubMed ID: 8444346
[TBL] [Abstract][Full Text] [Related]
32. A human Burkitt's lymphoma cell line carrying t(8;22) and t(14;18) translocations.
Kiefer T; Schüler F; Knopp A; Wimmer M; Hirt C; Schaefer HE; Dölken G
Ann Hematol; 2007 Nov; 86(11):821-30. PubMed ID: 17622530
[TBL] [Abstract][Full Text] [Related]
33. NF-kappa B activity is required for the deregulation of c-myc expression by the immunoglobulin heavy chain enhancer.
Kanda K; Hu HM; Zhang L; Grandchamps J; Boxer LM
J Biol Chem; 2000 Oct; 275(41):32338-46. PubMed ID: 10931834
[TBL] [Abstract][Full Text] [Related]
34. Variable IgH chain enhancer activity in Burkitt's lymphomas suggests an additional, direct mechanism of c-myc deregulation.
Jain VK; Judde JG; Max EE; Magrath IT
J Immunol; 1993 Jun; 150(12):5418-28. PubMed ID: 8515068
[TBL] [Abstract][Full Text] [Related]
35. Rearrangement of the c-myc oncogene with heavy-chain immunoglobulin enhancer in tumor DNA from an acute lymphoblastic leukemia patient.
Guerrasio A; Avanzi GC; Pegoraro L; Estivill X; Serra A; Giubellino MC; Fierro MT; Novarino A; Foa R; Saglio G
J Natl Cancer Inst; 1987 May; 78(5):845-51. PubMed ID: 3106693
[TBL] [Abstract][Full Text] [Related]
36. Prospective analysis of minimal bone marrow infiltration in pediatric Burkitt's lymphomas by long-distance polymerase chain reaction for t(8;14)(q24;q32).
Mussolin L; Basso K; Pillon M; D'Amore ES; Lombardi A; Luzzatto L; Zanesco L; Rosolen A
Leukemia; 2003 Mar; 17(3):585-9. PubMed ID: 12646948
[TBL] [Abstract][Full Text] [Related]
37. Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a distance of 300 kb downstream of MYC.
Zeidler R; Joos S; Delecluse HJ; Klobeck G; Vuillaume M; Lenoir GM; Bornkamm GW; Lipp M
Genes Chromosomes Cancer; 1994 Apr; 9(4):282-7. PubMed ID: 7519050
[TBL] [Abstract][Full Text] [Related]
38. Burkitt-like mutations in the c-myc gene locus in prolymphocytic leukemia.
Brennscheidt U; Eick D; Kunzmann R; Martens U; Kiehntopf M; Mertelsmann R; Herrmann F
Leukemia; 1994 May; 8(5):897-902. PubMed ID: 8182948
[TBL] [Abstract][Full Text] [Related]
39. Improved long-distance polymerase chain reaction for the detection of t(8;14)(q24;q32) in Burkitt's lymphomas.
Basso K; Frascella E; Zanesco L; Rosolen A
Am J Pathol; 1999 Nov; 155(5):1479-85. PubMed ID: 10550304
[TBL] [Abstract][Full Text] [Related]
40. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features.
Burmeister T; Schwartz S; Horst HA; Rieder H; Gökbuget N; Hoelzer D; Thiel E
Leukemia; 2005 Aug; 19(8):1391-8. PubMed ID: 15973450
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
